Zhu Shen of BioForesight Joins Editorial Advisory Board of PharmAsia News

SAN DIEGO--(Business Wire)--
Zhu Shen, Ph.D., MBA, chief executive officer of BioForesight, a
leading global life science consulting firm focusing on cross-Pacific
partnering, financing advisory, and public relations and media
strategy, has joined the editorial advisory board of
PharmAsiaNews.com.

"We are delighted to have Dr. Shen join our editorial advisory
board," said Joshua Berlin, executive editor and senior publications
manager at F-D-C Reports, Inc./Elsevier, publisher of
PharmAsiaNews.com and "The Pink Sheet" (www.thepinksheet.com), the
leading information source for the U.S. pharmaceutical industry since
1939.

"With Dr. Shen's knowledge, insight, and deep relationships in
Asia Pacific life science businesses, especially in the growing
markets of greater China, she will be an invaluable resource to our
readers, contributing guest columns about new trends in the industry
and helping to grow PharmAsiaNews.com."

Dr. Shen's first guest column on Chinese CRO trends is entitled
"The Art of Selecting Outsourcing Partners in China: Navigating the
Life Sciences Silk Road Frontier." Subscribers to PharmAsiaNews.com
may access the column at: www.pharmasianews.com. To download a
complimentary copy of the column and receive a 30-day free trial to
PharmAsiaNews.com, please visit: http://tinyurl.com/5qqjfj.

"I am honored to join the editorial advisory board of PharmAsia
News, whose extensive, in-depth, and up-to-date news and analysis
focusing on the Asia Pacific life science markets are unparalleled,"
said Shen. "Asia Pacific, especially greater China, represents one of
the most dynamic and rapidly growing markets for therapeutic drugs,
devices, diagnostics, and research tools. I look forward to working
with PharmAsia News to bring fresh, new perspective about Asia Pacific
life science trends and their impact on the global life science
businesses and communities."

Prior to founding BioForesight, Dr. Shen was Vice President of
Business Development at ItherX Pharmaceuticals (formerly Immusol) in
San Diego with novel programs in oncology and HCV. Her
responsibilities include leading ItherX's licensing, partnering, and
corporate communication. She also held positions at The Wilkerson
Group/IBM, Bayer, and Chiron, with increasing responsibilities in
marketing, strategic planning, and business development.

Dr. Shen is an organizer, speaker, and chair of numerous life
science business conferences on licensing, venture investing, and
cross-Pacific partnering/CRO trends. She serves on the Board of
Directors and chairs the Pacific Alliance & Entrepreneurship Committee
of Sino-American Biomedical and Pharmaceutical Professionals
Association (SABPA), the largest and most influential Chinese American
life science professional organization in Southern California. She
also serves on the BIOCOM Asia Task Force Steering Committee, and
Athena San Diego's Bioscience Committee. She earned her Ph.D. in
Biochemistry from the University of Colorado, and an MBA from the
Johnson School at Cornell University. She also attended Peking
University and Peking Union Medical College in China.

About BioForesight:

BioForesight, located in San Diego, California, is a leading
global life science consulting firm, providing services in licensing,
partnering, fund-raising, financing/venture capital advisory,
outsourcing strategy, public relations & media strategy,
commercialization and product launch strategy with a focus on
cross-Pacific businesses.

About PharmAsiaNews.com

PharmAsiaNews.com provides news and analysis on regulatory, legal
and financial developments affecting pharmaceutical, biologics and
medical device manufacturers doing business in China, India, Japan and
the Pacific Rim. Subscribers get original on-the-ground reporting from
news bureaus across Asia, guest columns, exclusive interviews, news
summaries, English translation summaries of Chinese and Japanese news,
and aggregated content from around the globe. PharmAsiaNews.com
leverages the editorial excellence of "The Pink Sheet" - the leading
information source for the U.S. pharmaceutical industry since 1939.
For a 30-day free trial, visit www.pharmasianews.com.

BioForesight
Zhu Shen, Ph.D., MBA
Chief Executive Officer
858-350-7669
bioforesight@gmail.com
www.bioforesight.biz
or
PharmAsiaNews.com
Joshua Berlin
Executive Editor & Senior Publications Manager
240-221-4465
j.berlin@elsevier.com

Copyright Business Wire 2008